No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
292 |
4. Check minimum number of eventsNone |
292 |
5. Include endpointsNone |
292 |
6. Filter based on genotype QC (FinnGen only) |
292 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M20
- Name in latin
- Alia deformitas hallucis [acquisita]
Similar endpoints
↥List of similar endpoints to
Other deformity of hallux (acquired)
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1768 | 1316 | 446 |
| Only index persons | 1661 | 1261 | 400 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.01 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 56.00 | 56.11 | 55.53 |
| Only index persons | 55.69 | 55.82 | 55.28 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 292 | 222 | 70 |
| Unadjusted period prevalence (%) | 0.06 | 0.08 | 0.03 |
| Median age at first event (years) | 55.15 | 53.92 | 59.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 267
- Matched controls
- 2669
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M20.3
ICD-10 Finland
Other deformity of hallux (acquired)
+∞
312.6
235
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
83.7
98.1
107
21
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
90.9
82
*
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
268.6
78.9
77
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
58.5
54
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
56.6
49.7
58
13
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
21.7
46.1
69
42
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
+∞
45.1
42
*
M20.2
ICD-10 Finland
Hallux rigidus
169.9
42.1
43
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
18.3
41.5
66
47
9271
FHL
Hallux surgery
422.9
38.0
37
*
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
37.4
35
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
36.3
34
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
35.2
33
*
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
383.1
34.8
34
*
7351A
ICD-9 Finland
Acquired deformities of toe, Hallux varus (acquired)
+∞
34.1
32
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
+∞
33.0
31
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
351.7
31.5
31
*
WX320
NOMESCO Finland
Spinalanesthesy
6.3
31.2
96
218
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
23.9
28.9
41
20
M25.5
ICD-10 Finland
Pain in joint
5.3
25.9
93
246
M16.1
ICD-10 Finland
Other primary coxarthrosis
43.5
25.5
31
8
73799
ICD-8 Finland
Hallux valgus and varus
+∞
24.3
23
*
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
262.4
24.0
24
*
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
250.4
23.0
23
*
NHG82
NOMESCO Finland
Fusion of other tarsal joint
+∞
22.2
21
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
238.6
21.9
22
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
238.6
21.9
22
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
47.8
21.8
26
6
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
9.9
21.4
44
52
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
21.1
20
*
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
21.1
20
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.4
20.2
143
669
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
25.0
16.7
23
10
N02AX02
ATC
tramadol; systemic, rectal
3.1
16.5
128
609
ZXA00
NOMESCO Finland
Right side
3.4
16.0
96
381
L17
ICPC
Foot/toe symptom/complaint
3.4
15.8
91
348
NH3EA
NOMESCO Finland
Feet X-ray examination with load
60.2
15.0
17
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
11.9
14.9
27
25
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
14.7
14
*
M79.6
ICD-10 Finland
Pain in limb
2.9
14.5
115
545
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.2
14.3
46
102
M01AX05
ATC
glucosamine; oral
3.9
14.3
65
204
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
9.0
14.2
30
37
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
8.9
13.7
29
36
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
17.4
13.7
21
13
S18
ICPC
Laceration/cut
2.7
13.5
130
687
M01AH05
ATC
etoricoxib; oral
2.7
13.4
158
938
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
21.3
12.6
18
9
B01AB05
ATC
enoxaparin; parenteral
2.9
12.4
90
395
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
14.3
12.1
20
15
M19.9
ICD-10 Finland
Arthrosis, unspecified
11.3
12.0
22
21
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
49.0
12.0
14
*
Z01.2
ICD-10 Finland
Dental examination
2.6
11.8
120
641
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
11.8
107
534
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
125.1
11.5
12
*
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.5
11.4
34
69
L15
ICPC
Knee symptom/complaint
3.3
11.3
63
230
1221
FHL
Arthroscopy and meniscus surgery
26.3
11.3
15
6
N03AX12
ATC
gabapentin; oral
3.6
11.0
53
172
M09AX01
ATC
hyaluronic acid; parenteral
10.2
11.0
21
22
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
62.5
10.7
12
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
62.5
10.7
12
*
M13.9
ICD-10 Finland
Arthritis, unspecified
15.0
10.6
17
12
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
7.6
10.5
24
34
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
114.2
10.5
11
*
M01AE01
ATC
ibuprofen; systemic, rectal
3.3
9.8
241
1970
ZXA05
NOMESCO Finland
Left side
2.7
9.6
77
352
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
31.2
9.5
12
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
103.5
9.5
10
*
SPAT1153
SPAT
Removal of sutures
2.5
9.5
93
475
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
9.4
9
*
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
+∞
9.4
9
*
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
9.4
9
*
L84
ICD-10 Finland
Corns and callosities
9.6
9.2
18
20
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
9.1
105
580
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
38.1
9.1
11
*
J01DB01
ATC
cefalexin; oral
2.6
9.0
220
1722
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
8.9
86
431
M03BX02
ATC
tizanidine; oral
2.2
8.8
170
1182
A02BC03
ATC
lansoprazole; oral
2.4
8.8
85
428
N03AX16
ATC
pregabalin; oral
2.6
8.7
70
319
M01AX17
ATC
nimesulide; oral
2.5
8.6
74
349
P01BA02
ATC
hydroxychloroquine; oral
7.1
8.5
20
30
M54.4
ICD-10 Finland
Lumbago with sciatica
3.0
8.5
51
193
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
92.8
8.5
9
*
L13
ICPC
Hip symptom/complaint
3.1
8.4
48
177
A02BC05
ATC
esomeprazole; systemic
2.2
8.3
120
727
J02AC01
ATC
fluconazole; systemic
2.1
8.1
127
795
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
10.5
8.1
15
15
M01AH01
ATC
celecoxib; oral (coxibs)
2.8
8.1
56
232
J01FF01
ATC
clindamycin; systemic
2.4
8.0
77
383
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.8
7.8
25
56
M77.4
ICD-10 Finland
Metatarsalgia
4.6
7.8
26
61
N02BE01
ATC
paracetamol; systemic, rectal
2.6
7.7
231
1903
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
25.8
7.6
10
*
M02AA07
ATC
piroxicam; topical
2.1
7.6
108
646
UJF32
NOMESCO Finland
Coloscopy
2.3
7.5
76
389
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
82.2
7.5
8
*
H02AB06
ATC
prednisolone; systemic
2.1
7.4
118
735
L16
ICPC
Ankle symptom/complaint
3.3
7.3
36
119
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
7.3
49
199
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
+∞
7.3
7
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
7.3
7
*
M22.4
ICD-10 Finland
Chondromalacia patellae
30.9
7.2
9
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.5
7.2
61
284
WX110
NOMESCO Finland
Local anesthesy
2.0
7.1
173
1269
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
7.0
53
231
R51.80
ICD-10 Finland
Headache
3.0
7.0
41
154
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
7.0
137
924
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
3.2
7.0
36
124
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.9
6.8
27
75
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
41.1
6.8
8
*
B01AF01
ATC
rivaroxaban; oral
3.5
6.6
30
94
WX002
NOMESCO Finland
Sedation and analgesia
2.4
6.5
60
291
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
6.5
176
1321
M48.0
ICD-10 Finland
Spinal stenosis
3.0
6.5
37
136
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
71.4
6.5
7
*
NG2AA
NOMESCO Finland
Patella X-ray examination
71.4
6.5
7
*
M01AC06
ATC
meloxicam; systemic, rectal
2.0
6.4
100
607
E0000UV
ATC
NA
2.0
6.3
107
673
ZXA10
NOMESCO Finland
Bilateral
2.3
6.3
61
303
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
18.5
6.3
9
5
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.9
6.3
39
149
9351
FHL
Metatarsus osteotomies
+∞
6.3
6
*
M19.2
ICD-10 Finland
Other secondary arthrosis
+∞
6.3
6
*
WX214
NOMESCO Finland
Plexus blockade at the ankle
+∞
6.3
6
*
M01AB05
ATC
diclofenac; systemic, rectal
1.9
6.2
168
1250
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.1
112
722
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.7
6.1
25
72
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.5
6.1
27
83
N06AA09
ATC
amitriptyline; systemic
3.0
6.1
34
122
N05BA01
ATC
diazepam; systemic, rectal
2.6
6.1
45
194
WX290
NOMESCO Finland
Other blockade of nerve
2.0
6.0
102
639
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
6.0
140
984
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
17
9.25
12.10
1.5
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
220
1669
2.29
8.59
5.9
3.3
mm/h
11.0
12.5
1.29
206
1503
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
146
950
2.07
8.54
4.1
4.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
53
232
2.57
8.02
1.3
1.3
titre
416.0
477.1
—
10
41
(3007853) Bacteria identified in Skin by Aerobe culture
47
200
2.61
7.52
2.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
5
20.63
7.18
1.4
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
63
315
2.28
7.08
1.4
1.2
iu/ml
28.5
14.8
0.46
26
92
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
271
2330
3.27
6.99
15.8
13.0
mg/l
20.4
24.5
1.40
222
1750
(3044927) Protein electrophoresis panel - Urine
12
21
5.92
6.64
1.2
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
52
250
2.31
6.37
22.7
21.7
inr
1.7
1.2
—
7
35
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
144
1003
1.86
6.30
2.3
2.2
nmol/l
82.0
78.8
0.65
124
883
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
90
543
1.95
6.09
2.4
2.0
mg/l
2.7
3.0
0.76
82
448
(3013826) Glucose [Moles/volume] in Serum or Plasma
177
1338
1.82
5.73
3.3
4.4
mmol/l
6.4
6.7
2.22
164
1244
(3024561) Albumin [Mass/volume] in Serum or Plasma
141
996
1.80
5.73
2.9
4.9
g/l
35.6
35.6
0.02
120
920
(3019198) Lymphocytes [#/volume] in Blood
155
1129
1.79
5.65
6.5
4.7
e9/l
1.9
2.0
0.14
139
988
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
103
664
1.85
5.62
2.7
3.3
ng/l
881.6
1210.3
1.07
84
561
(3042936) Bacteria identified in Isolate by Culture
54
281
2.13
5.43
1.8
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
109
726
1.80
5.29
6.2
4.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
222
1826
1.90
5.19
7.5
7.4
u/l
73.6
78.9
1.82
206
1705
(3006315) Basophils [#/volume] in Blood
150
1110
1.72
4.95
6.6
4.6
e9/l
0.0
0.0
0.09
131
952
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
292
2.04
4.89
1.4
1.1
u/ml
3.0
3.2
0.02
20
115
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
229
1917
1.90
4.88
4.7
4.0
pmol/l
14.9
14.9
0.04
206
1728
(3013650) Neutrophils [#/volume] in Blood by Automated count
173
1336
1.72
4.85
7.8
8.7
e9/l
4.0
4.1
0.37
154
1161
(3026493) Urate [Moles/volume] in Serum or Plasma
81
505
1.84
4.82
1.9
2.4
umol/l
6867.6
14045.5
0.69
70
437
(3001604) Monocytes [#/volume] in Blood
149
1107
1.71
4.80
6.6
4.6
e9/l
0.6
0.6
0.29
132
946
(3022096) Basophils/100 leukocytes in Blood
138
1008
1.70
4.71
6.5
4.5
%
0.7
0.7
0.42
127
937
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
144
1069
1.68
4.59
4.0
5.3
mmol/l
1.2
1.2
0.46
132
964
(4306422)
10
21
4.90
4.56
1.4
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
98
660
1.73
4.45
2.0
2.0
u/l
202.7
172.1
0.14
92
630
(3021960) Folate [Moles/volume] in Serum or Plasma
86
558
1.77
4.44
1.4
1.5
nmol/l
21.9
21.3
0.13
75
469
(3019550) Sodium [Moles/volume] in Serum or Plasma
275
2488
2.81
4.44
17.2
15.3
mmol/l
139.7
139.7
0.17
269
2413
(3019069) Monocytes/100 leukocytes in Blood
141
1050
1.66
4.37
7.3
4.9
%
8.8
8.6
0.49
131
982
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
22
4.67
4.33
1.1
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
275
2493
2.77
4.32
17.4
15.5
mmol/l
4.0
4.0
1.35
268
2411
(3006504) Eosinophils/100 leukocytes in Blood
140
1044
1.66
4.30
6.8
4.6
%
2.8
2.9
0.30
127
969
(3002030) Lymphocytes/100 leukocytes in Blood
143
1073
1.65
4.28
6.8
4.8
%
28.0
27.8
0.06
132
1000
(3018010) Neutrophils/100 leukocytes in Blood
141
1055
1.65
4.26
6.4
4.6
%
56.7
57.0
0.14
131
988
(3000963) Hemoglobin [Mass/volume] in Blood
285
2673
3.76
4.26
24.4
19.1
g/l
133.6
133.8
0.11
280
2623
(3026361) Erythrocytes [#/volume] in Blood
285
2673
3.76
4.26
24.2
19.0
e12/l
4.4
4.5
0.89
276
2577
(3035941) MCH [Entitic mass]
285
2673
3.76
4.26
24.1
18.9
pg
30.4
30.2
1.22
280
2623
(3010813) Leukocytes [#/volume] in Blood
285
2674
3.74
4.26
24.3
19.1
e9/l
6.4
6.5
0.54
276
2576
(3007461) Platelets [#/volume] in Blood
285
2672
3.78
4.25
24.2
19.0
e9/l
257.4
253.7
0.44
277
2584
(3024731) MCV [Entitic volume]
285
2672
3.78
4.25
24.1
19.0
fl
91.7
91.0
2.16
280
2622
(3013115) Eosinophils [#/volume] in Blood
151
1153
1.64
4.19
6.9
5.0
e9/l
0.2
0.2
0.48
137
1001
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
129
950
1.64
4.11
2.1
1.9
pmol/l
101.2
97.5
0.33
58
479
(3044889) 12 lead EKG panel
204
1686
1.70
4.11
4.3
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
273
2480
2.55
4.01
15.7
12.6
—
—
—
0
0
(3036489) Thrombin time
20
76
2.75
3.99
1.8
2.0
s
20.7
21.0
0.13
15
69
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
255
2259
2.02
3.95
5.9
4.8
mu/l
1.9
2.5
0.64
235
2032
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
152
1179
1.60
3.84
4.9
6.4
mmol/l
1.2
1.2
0.92
126
1005
(3001122) Ferritin [Mass/volume] in Serum or Plasma
130
975
1.60
3.76
3.2
2.6
ug/l
100.3
110.7
0.37
118
899
(3037467) Urinalysis macro (dipstick) panel - Urine
191
1574
1.62
3.68
5.7
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
252
2239
1.92
3.64
5.8
5.7
mmol/mol
38.9
39.9
1.66
237
2034
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
279
2585
2.78
3.47
11.7
9.5
u/l
24.5
24.4
0.04
269
2482
(3032080) INR in Blood by Coagulation assay
121
909
1.57
3.39
9.1
7.9
inr
1.3
1.2
0.57
40
275
(3044941) Cell count panel - Synovial fluid
7
10
7.14
3.38
1.9
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
264
2398
2.05
3.34
4.7
4.3
mmol/l
4.8
4.8
0.09
246
2193
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
50
2.89
3.13
1.1
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
261
2379
1.91
3.00
4.5
4.3
mmol/l
1.6
1.5
0.62
244
2156
(3024263) Appearance of Synovial fluid
5
5
10.14
2.99
1.4
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
46
2.91
2.96
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
217
1.86
2.94
4.0
3.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
91
661
1.55
2.87
2.2
2.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
44
265
1.78
2.87
1.8
2.4
ug/g
152.8
147.7
0.02
33
206
(40768797) Stomach Pathology biopsy report
49
306
1.72
2.83
1.2
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
31
3.30
2.80
4.0
2.5
e9/l
4.4
4.4
—
10
31
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
266
2455
1.94
2.70
5.3
4.9
mmol/l
2.8
2.8
0.02
249
2238
(3020564) Creatinine [Moles/volume] in Serum or Plasma
274
2558
2.15
2.64
18.4
15.6
umol/l
73.2
75.0
0.70
274
2558
(3000494) Fungus identified in Specimen by Culture
43
264
1.74
2.63
1.4
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
106
810
1.48
2.60
3.4
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
75
2.34
2.56
1.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
578
1.53
2.56
6.1
6.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
33
3.10
2.55
4.0
3.2
%
62.4
60.2
—
10
33
(3026008) Bacteria identified in Urine by Culture
102
779
1.48
2.49
3.3
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
68
477
1.55
2.48
4.8
4.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
116
911
1.45
2.45
3.5
3.5
ng/l
20.4
79.7
0.89
70
633
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
39
238
1.74
2.44
2.1
4.9
u/l
240.6
232.4
0.28
34
224
(3037121) Protein [Mass/volume] in Urine
18
85
2.19
2.34
2.7
3.3
g/l
0.1
0.3
—
7
30
(3019309) Folate [Moles/volume] in Red Blood Cells
63
443
1.54
2.26
1.7
1.6
nmol/l
1242.7
1210.1
0.10
52
313
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
249
2283
1.62
2.23
4.1
3.9
mmol/l
1.3
1.3
0.30
231
2064
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
257
2375
1.68
2.22
5.0
4.5
mmol/l
5.8
6.0
2.48
234
2148
(3004789) Transferrin [Mass/volume] in Serum or Plasma
48
318
1.61
2.22
2.4
2.3
g/l
2.4
2.3
0.09
42
296
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
9
5.63
2.22
1.2
2.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
146
1.86
2.14
5.5
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
484
1.50
2.12
2.4
2.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
10
5.07
2.08
1.6
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
89
683
1.44
2.07
3.1
2.9
e6/l
77.9
64.4
0.11
67
521
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
84
638
1.44
2.06
1.6
1.6
mmol/l
1.3
1.3
0.04
70
519
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
83
2.11
2.05
1.7
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
93
721
1.43
2.04
3.0
3.8
ph
7.4
7.4
1.15
17
126
(3015377) Calcium [Moles/volume] in Serum or Plasma
107
851
1.41
2.04
2.6
3.5
mmol/l
2.4
2.4
0.22
92
739
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
45
302
1.58
1.98
2.4
2.3
%
20.9
22.1
0.22
38
254
(21494434) Karyotype in Bone marrow
7
21
3.39
1.97
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
19
99
1.98
1.95
1.2
1.2
—
—
—
0
0
(4024509)
6
16
3.80
1.94
2.2
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
148
1253
1.37
1.90
4.9
6.8
umol/l
9.9
10.8
0.98
140
1180
(3023511) Choriogonadotropin [Units/volume] in Urine
7
23
3.09
1.81
1.4
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
170
1478
1.36
1.81
3.5
3.0
u/l
42.6
43.2
0.05
158
1361
(3020682) Albumin/Creatinine [Ratio] in Urine
93
739
1.38
1.74
3.2
3.9
mg/mmol
2.0
7.1
3.08
48
460
(3012516) Albumin [Mass/volume] in Urine
88
693
1.39
1.74
2.5
3.1
mg/l
2592.5
342.8
0.87
50
413
(3037756) Immunofixation for Serum or Plasma
11
48
2.34
1.72
1.0
2.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
92
736
1.37
1.64
2.6
2.5
u/l
68.7
56.8
0.93
83
673
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
65
491
1.42
1.63
1.8
1.7
mg/l
1.3
1.2
0.21
50
363
(3011397) Hemoglobin [Presence] in Urine by Test strip
67
509
1.41
1.62
4.3
3.7
—
—
—
0
0
(4010399)
28
178
1.63
1.55
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
51
374
1.44
1.50
1.6
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
132
1127
1.31
1.49
4.9
3.6
estimate
0.0
0.0
0.00
23
201
(40761535) Cells panel - Urine sediment
28
180
1.61
1.49
3.2
3.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
68
526
1.38
1.48
1.9
1.6
pmol/l
429.6
14019137.5
0.50
57
428
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
349
1.45
1.48
2.7
2.6
e6/l
3.7
3.4
0.06
22
194
(3042631) Mycobacterium sp identified in Specimen
7
28
2.54
1.46
2.1
2.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
22
2.76
1.44
1.7
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
97
797
1.33
1.43
3.7
3.5
e6/l
132.7
105.5
0.16
69
565
(3014051) Protein [Presence] in Urine by Test strip
10
46
2.22
1.41
2.8
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
370
1.42
1.41
2.6
2.5
e6/l
1.4
1.1
0.19
24
213
(3009261) Glucose [Presence] in Urine by Test strip
133
1146
1.29
1.38
4.8
3.7
estimate
0.0
0.0
0.80
25
198
(3023520) Reticulocytes [#/volume] in Blood
27
176
1.59
1.37
2.0
2.6
e9/l
61.7
72.1
0.54
19
132
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
68
1.95
1.35
1.7
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
426
1.39
1.35
3.4
3.6
ng/l
263.8
433.4
0.32
45
336
(3021601) Nitrite [Presence] in Urine by Test strip
132
1139
1.29
1.34
6.1
5.2
estimate
0.0
0.0
0.00
25
203
(3003458) Phosphate [Moles/volume] in Serum or Plasma
39
278
1.46
1.33
3.4
5.1
mmol/l
1.0
1.1
0.27
34
253
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
57
437
1.38
1.31
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
24
2.53
1.31
1.2
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
24
2.53
1.31
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
24
2.53
1.31
1.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
18
2.81
1.29
2.6
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
25
2.43
1.25
1.2
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
25
2.43
1.25
1.2
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
25
2.43
1.25
1.2
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
24
156
1.59
1.25
1.3
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
49
2.08
1.23
1.3
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
214
1978
1.31
1.22
18.8
16.1
%
13.7
13.7
0.03
208
1937
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.2
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
725
1.28
1.13
2.5
3.0
mmol/l
7.4
6.9
0.43
72
599
(3045414) Leukocytes [Presence] in Urine
15
88
1.74
1.13
2.6
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
114
984
1.26
1.12
2.1
2.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
25
169
1.52
1.11
3.7
3.6
%
0.2
0.4
—
5
34
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
86
718
1.28
1.10
3.1
3.2
u/l
35.5
29.6
0.71
78
681
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
59
469
1.32
1.09
1.9
3.1
mmol/l
2.4
2.5
2.19
49
418
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
32
2.22
1.09
1.4
2.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
20
129
1.59
1.08
1.9
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
75
617
1.29
1.08
5.7
3.7
estimate
0.0
0.0
0.50
25
202
(3019150) Specific gravity of Urine by Refractometry
62
497
1.31
1.08
5.8
3.8
kg/l
1.0
1.0
0.13
15
66
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
171
1.51
1.06
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
163
1.51
1.05
3.5
3.7
%
0.0
0.0
—
5
41
(3017181) Myelocytes/100 leukocytes in Blood
27
189
1.47
1.03
4.2
3.6
%
0.5
1.1
—
6
58
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
10
53
1.92
1.02
1.0
1.3
—
1.4
—
0
5
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
242
2294
1.32
1.00
15.0
12.4
ml/min/173m2
79.0
78.6
0.10
205
1856
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
116
1.59
0.99
2.4
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
36
1.97
0.97
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
117
0.50
0.96
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
25
176
1.46
0.94
4.4
3.7
%
0.0
0.2
—
5
52
(40760888) Immunoglobulin light chains.free panel - Serum
9
52
1.75
0.93
1.1
4.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
73
610
1.26
0.93
3.0
2.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
73
611
1.26
0.91
1.4
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
169
1.46
0.91
1.1
1.2
iu/ml
110.6
139.1
—
8
73
(3023368) Bacteria identified in Blood by Culture
70
584
1.26
0.90
3.8
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
149
1350
1.21
0.88
2.7
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
112
1.55
0.87
3.6
8.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
103
901
1.22
0.86
5.3
3.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
53
430
1.28
0.85
5.5
4.5
ug/l
2.5
3.1
0.27
47
382
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
121
1.52
0.85
1.3
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
8
47
1.72
0.81
4.3
4.0
nmol/l
0.7
0.8
—
8
39
(3019225) pH of Specimen
30
226
1.36
0.80
3.7
4.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
34
1.78
0.76
1.0
1.3
u/l
33.8
12.4
—
6
29
(3000991) Gas panel - Venous blood
26
193
1.38
0.76
4.3
6.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
274
1.32
0.74
6.1
7.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
38
1.86
0.74
3.6
2.9
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
40
1.77
0.71
1.0
1.3
—
1.0
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
40
1.77
0.71
1.3
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
34
267
1.31
0.71
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
26
1.94
0.71
2.2
2.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
26
1.94
0.71
1.2
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
43
1.64
0.67
1.3
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
72
623
1.21
0.67
3.1
2.8
e6/l
0.7
0.6
0.11
55
469
(21494755) Public health laboratory ask at order entry panel
14
199
0.69
0.64
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
121
1.43
0.64
1.2
1.4
—
24.4
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
49
1.65
0.62
1.0
1.3
—
4.0
—
0
10
(3023419) Bacteria identified in Sputum by Culture
5
30
1.68
0.61
1.4
3.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
175
1.34
0.60
1.3
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
21
0.00
0.60
0.0
3.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
25
193
1.32
0.60
2.3
3.5
mmol/l
1.2
1.2
0.17
19
161
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
54
1.49
0.57
2.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
90
1.47
0.56
1.8
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
37
1.63
0.56
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
38
1.59
0.54
1.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
61
1.49
0.54
2.9
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
91
1.45
0.54
1.2
1.9
g/l
3.4
3.0
—
7
69
(3013512) EKG study
78
694
1.17
0.53
5.0
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
9
65
1.40
0.51
4.2
2.9
u/ml
0.6
0.4
—
9
38
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
172
1.30
0.50
3.1
3.5
u/ml
17.2
78.8
1.67
22
166
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
310
1.22
0.49
5.4
4.2
%
33.7
33.5
0.06
30
198
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
164
1.30
0.48
2.0
2.8
ml/min/173m2
60.2
60.4
0.01
12
60
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
49
1.44
0.46
1.0
1.3
—
2.8
—
0
9
(40761536) Microorganisms panel - Urine sediment
24
193
1.27
0.45
5.5
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
129
0.69
0.44
1.8
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
31
1.62
0.43
1.6
1.9
pg
30.0
31.7
—
5
31
(3011288) Drugs identified in Urine by Screen method
5
33
1.52
0.41
1.6
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
59
1.37
0.41
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
270
1.21
0.40
1.5
1.9
—
—
—
0
0
(4281824)
5
34
1.48
0.40
1.6
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
103
0.67
0.40
2.0
5.2
%
2.1
1.5
—
7
97
(3051651) Icteric interference index of Serum or Plasma
0
18
0.00
0.40
0.0
3.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
7
105
0.66
0.40
2.0
5.1
%
1.2
0.9
—
7
100
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
133
1.30
0.39
1.6
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
35
1.44
0.39
4.2
4.0
u/ml
70.9
102.7
—
5
35
(3045424) Erythrocytes [Presence] in Urine
5
35
1.44
0.39
2.0
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
112
1045
1.12
0.38
10.8
8.2
e9/l
0.0
0.0
0.64
92
849
(3009542) Hematocrit [Volume Fraction] of Blood
223
2162
1.13
0.37
17.1
14.0
%
39.9
39.1
0.91
151
1508
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
81
1.37
0.36
2.5
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
99
1.33
0.36
1.2
1.9
g/l
3.6
3.6
—
7
67
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
99
1.33
0.36
1.2
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
99
1.33
0.36
1.2
1.9
g/l
7.8
7.0
—
7
69
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
16
126
1.29
0.36
2.6
3.5
kpa
5.5
5.1
0.48
16
120
(3026782) Osmolality of Urine
53
474
1.14
0.35
2.6
2.6
mosm/kgh2o
515.9
534.9
0.24
44
395
(3019230) Fractional oxyhemoglobin in Venous blood
6
43
1.40
0.35
1.8
2.2
%
67.2
60.4
—
6
43
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
73
1.38
0.35
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
1.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
275
1.18
0.34
1.7
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
22
182
1.23
0.34
3.0
2.9
ng/l
156.6
196.6
0.35
22
172
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
47
1.28
0.32
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
83
1.34
0.32
2.2
2.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.4
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
52
1.35
0.31
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
52
1.35
0.31
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
38
335
1.15
0.31
1.5
1.4
—
—
—
0
0
(4035726)
19
228
0.82
0.30
1.5
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
93
1.30
0.30
1.2
1.9
g/l
10.3
10.5
—
7
76
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
195
1.19
0.29
2.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
91
852
1.10
0.28
2.5
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
29
253
1.16
0.27
3.7
6.3
mmol/l
0.7
1.2
0.36
24
198
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
74
0.67
0.26
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
74
0.67
0.26
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
75
0.66
0.26
1.4
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
123
1.23
0.26
2.7
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
73
1.24
0.25
1.0
3.5
—
3.0
—
0
8
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
75
1.21
0.25
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
180
0.82
0.25
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
9
76
1.19
0.25
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
643
1.10
0.24
4.7
3.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
17
200
0.84
0.23
1.9
2.7
kpa
4.7
4.4
0.20
17
190
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.6
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
38
1.32
0.23
1.0
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
39
1.29
0.23
1.4
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
40
1.25
0.22
1.6
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
5.2
4.2
umol/l
424.0
361.5
—
5
35
(3017569) Oxygen content in Arterial blood
0
11
0.00
0.21
0.0
7.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
13
0.00
0.21
0.0
6.8
—
—
—
0
0
(3020891) Body temperature
10
80
1.26
0.20
2.1
4.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
5.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
0.6
—
0
9
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
5.6
—
0
6
(3000764) Benzodiazepines [Presence] in Urine
6
50
1.20
0.20
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
50
1.20
0.20
1.5
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
50
1.20
0.20
1.5
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
6
51
1.18
0.19
2.0
1.3
e6/l
1.3
2.7
—
6
39
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
6
51
1.18
0.19
2.0
1.4
e6/l
63.7
126.7
—
6
41
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
147
1.17
0.18
3.1
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
34
310
1.11
0.18
1.2
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
68
1.18
0.16
1.6
2.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
72
1.11
0.16
1.1
1.0
—
1.1
—
0
6
(4034850)
8
73
1.10
0.16
13.9
9.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
11
128
0.85
0.14
1.3
1.5
g/l
2.1
1.2
0.59
11
114
(40768793) Breast Pathology biopsy report
8
100
0.79
0.14
1.1
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
41
437
0.93
0.13
1.3
1.5
g/l
2.7
2.3
0.51
23
264
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
229
1.10
0.13
2.1
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
95
1.16
0.12
2.6
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
241
1.09
0.11
1.7
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
29
310
0.93
0.10
2.1
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
22
238
0.92
0.10
2.5
3.3
kpa
6.0
5.8
0.52
22
226
(3019060) Gas panel - Arterial blood
13
145
0.89
0.09
1.9
4.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
47
1.06
0.09
1.6
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.6
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
65
0.77
0.08
3.0
3.2
—
—
—
0
0
(3000492) Spirometry study
21
195
1.08
0.08
1.0
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
20
215
0.93
0.08
3.7
6.5
%
96.5
95.0
1.39
20
209
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
186
1.08
0.07
1.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
128
1.10
0.07
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
105
0.85
0.06
1.8
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
168
1.08
0.06
1.5
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
161
0.93
0.05
3.5
2.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
14
130
1.08
0.04
1.6
2.3
%
0.6
0.7
0.21
14
121
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
521
0.97
0.03
1.3
1.2
u/ml
0.6
1.0
1.17
18
128
(3004119) Hemoglobin [Mass/volume] in Venous blood
17
162
1.05
0.02
1.8
2.9
g/l
128.7
128.1
0.03
17
157
(3000330) Specific gravity of Urine by Test strip
14
138
1.02
0.00
3.0
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
148
1.01
0.00
1.1
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
113
0.97
0.00
1.1
1.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
13
125
1.04
0.00
5.1
6.4
%
0.4
0.7
2.48
13
125
(3002173) Hemoglobin [Mass/volume] in Arterial blood
20
205
0.97
0.00
4.0
6.8
g/l
122.3
119.7
0.18
20
197
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
124
0.97
0.00
5.0
6.4
%
1.5
1.6
0.06
12
124
(3014576) Chloride [Moles/volume] in Serum or Plasma
28
276
1.02
0.00
3.7
5.5
mmol/l
102.6
104.0
0.91
28
269
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
36
356
1.01
0.00
5.2
4.1
%
20.0
21.2
0.32
20
178
(4094501)
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
59
1.02
0.00
1.0
4.6
u/ml
1356.3
202.2
—
6
54
(3024928) Oxygen saturation in Venous blood
6
59
1.02
0.00
2.3
2.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
2.2
—
4.8
—
0
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
32.1
—
0
9
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1314.1
—
0
9
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
69
0.87
0.00
1.2
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
6
60
1.00
0.00
2.0
1.3
mg/l
373.0
442.9
—
6
55
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
50
1.00
0.00
1.6
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.4
—
0
6
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
3.9
—
59.6
—
0
9
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
99.6
—
0
7
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
69
0.87
0.00
1.8
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
22.6
—
0
6
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
68
0.88
0.00
2.0
1.3
pmol/l
72.0
380.5
—
6
68
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.7
—
179.2
—
0
9
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
14.3
—
0
7
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
-0.00
0.0
1.0
—
160.4
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_HALLUDEFORMOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_HALLUDEFORMOTH | 0.675 [0.54, 0.85] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.581 |
During the follow-up period (1.1.1998 — 31.12.2019), 85 out of 970 females with M13_HALLUDEFORMOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_HALLUDEFORMOTH | 0.93 [0.7, 1.24] | 0.625 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 341 males with M13_HALLUDEFORMOTH died.
Mortality risk
Mortality risk for people of age
years, who have M13_HALLUDEFORMOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.058% | 0.114% |
| 5 | 0.403% | 1.004% |
| 10 | 1.009% | 2.475% |
| 15 | 2.078% | 4.616% |
| 20 | 3.681% | 7.893% |
Relationships between endpoints
↥Index endpoint: M13_HALLUDEFORMOTH – Other deformity of hallux (acquired)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data